HIM
AVNS

Hillsdale Investment Management’s Avanos Medical AVNS Stock Holding History

Hillsdale Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$4.9K – 643
2025
Q2 		$4.9K Hold
400
– – ﹤0.01% 599
2025
Q1 		$5.73K Sell
400
-176,600
-100% -$2.76M ﹤0.01% 563
2024
Q4 		$2.82M Buy
177,000
+13,720
+8% +$272K 0.14% 190
2024
Q3 		$3.92M Buy
+163,280
New +$3.73M 0.3% 125
2023
Q3 		– Sell
-86,600
Closed -$2.21M – 568
2023
Q2 		$2.21M Sell
86,600
-100,700
-54% -$2.65M 0.2% 161
2023
Q1 		$5.57M Hold
187,300
– – 0.48% 63
2022
Q4 		$5.07M Buy
187,300
+4,900
+3% +$120K 0.43% 67
2022
Q3 		$3.97M Buy
182,400
+13,000
+8% +$340K 0.36% 109
2022
Q2 		$4.63M Buy
169,400
+27,100
+19% +$779K 0.37% 93
2022
Q1 		$4.77M Buy
+142,300
New +$4.58M 0.31% 119

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Hillsdale Investment Management's AVNS Position: Q3 2025 in Review

Hillsdale Investment Management sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 400 shares — an estimated $4.9K sold.

Hillsdale Investment Management first reported a position in AVNS in Q1 2022 and held it in 10 quarters. The position peaked at $5.57M in Q1 2023. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Hillsdale Investment Management reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 400 Avanos Medical shares in Q3 2025, an estimated $4.9K.
  • Hillsdale Investment Management first reported a position in Avanos Medical in Q1 2022 and held it in 10 quarters.
  • Hillsdale Investment Management's Avanos Medical position peaked at $5.57M in Q1 2023.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.